Bionure Revenue and Competitors
Estimated Revenue & Valuation
- Bionure's estimated annual revenue is currently $2M per year.
- Bionure's estimated revenue per employee is $155,000
Employee Data
- Bionure has 13 Employees.
- Bionure grew their employee count by 8% last year.
Bionure's People
| Name | Title | Email/Phone |
|---|
Bionure Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2M | 13 | 8% | N/A | N/A |
What Is Bionure?
Bionure is a clinical-stage biotech company developing therapies for the treatment of rare ophthalmological diseases for which no treatment options are nowadays available. We focus in particular in two conditions in which patients suffer from vision impairment and blindness, paralysis and even death: acute optic neuritis and neuromyelitis optica. Our lead candidate BN201 is a small molecule, new chemical entity, first-in-class drug at IND-stage that has been shown to promote neuroprotection and remyelination in several animal models of damage. BN201 has been granted orphan designation for acute optic neuritis in Europe and the US. Bionure is undertaking Phase 1 clinical trial of BN201 in the United Kingdom. With patients in mind, we have built an extraordinary committed team of experts in neuro-ophthalmology and neuro-inflammation, passionate about bringing meaningful therapies to society with the aim of changing the life of thousands of people.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Barcelona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2M | 13 | 0% | N/A |
#2 | $1.9M | 13 | -19% | N/A |
#3 | $1.6M | 13 | -13% | N/A |
#4 | $2.4M | 13 | -24% | N/A |
#5 | $1.4M | 13 | 8% | N/A |